Search by Drug Name or NDC

    NDC 00781-3317-80 Oxaliplatin 5 mg/mL Details

    Oxaliplatin 5 mg/mL

    Oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is OXALIPLATIN.

    Product Information

    NDC 00781-3317
    Product ID 0781-3317_d65e5aba-65a6-4d70-ae9f-98dc57e0fdc0
    Associated GPIs 21100028002030
    GCN Sequence Number 059163
    GCN Sequence Number Description oxaliplatin VIAL 100MG/20ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24701
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name Oxaliplatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxaliplatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name Sandoz Inc
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078817
    Listing Certified Through 2024-12-31

    Package

    NDC 00781-3317-80 (00781331780)

    NDC Package Code 0781-3317-80
    Billing NDC 00781331780
    Package 1 VIAL, SINGLE-USE in 1 CARTON (0781-3317-80) / 20 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2015-03-01
    NDC Exclude Flag N
    Pricing Information N/A